丹参酚通过p53介导机制特异性诱导U2-OS细胞凋亡抑制骨肉瘤
该研究结合斑马鱼异种移植模型与U2-OS细胞实验,探讨丹参主要成分丹参酚的抗骨肉瘤作用及机制。结果显示丹参酚在2至20 ng/mL范围内显著抑制斑马鱼幼鱼体内U2-OS肿瘤生长,体外呈剂量依赖性抗增殖和促凋亡,且对bMSCs无抑制作用。分子层面丹参酚激活p53信号通路及其上游JNK和ATM信号,上调促凋亡基因并下调Bcl-2蛋白。
要点
- 丹参酚在2至20 ng/mL范围内抑制斑马鱼体内U2-OS肿瘤生长。
- 丹参酚剂量依赖性抑制U2-OS细胞增殖并诱导凋亡,对bMSCs无抑制。
- 丹参酚通过激活p53信号通路及其上游JNK、ATM信号诱导U2-OS细胞凋亡。
核心结论
- 丹参酚通过激活p53信号通路特异性诱导U2-OS细胞凋亡,是骨肉瘤治疗的潜在候选药物。
研究设计与样本
- 研究采用体内斑马鱼异种移植模型和体外U2-OS细胞实验。
- 体外采用CCK-8 assay、DAPI和γ-H2A.X免疫荧光染色及流式细胞术检测抗增殖和促凋亡效应。
- 采用qPCR和Western blot检测丹参酚对U2-OS细胞凋亡的分子作用及机制。
主要发现
- 体内数据显示丹参酚在2至20 ng/mL浓度下显著抑制斑马鱼幼鱼体内U2-OS肿瘤生长。
- 体外数据显示丹参酚对U2-OS细胞呈剂量依赖性显著抗增殖和促凋亡作用。
- 丹参酚对bMSCs无抑制作用,提示其对正常成骨细胞安全。
- 分子数据显示丹参酚通过磷酸化和切割激活p53信号相关蛋白(p-p53、Bax、CASP3、CASP9)及其上游JNK(p-JNK、p-c-JUN)和ATM(p-ATM)信号分子。
- 丹参酚上调促凋亡基因NOXA、PUMA、TP53、BAX和BIM,下调Bcl-2蛋白。
临床怎么用
- 丹参酚在2至20 ng/mL范围内具有体内抗骨肉瘤活性,为后续开发提供实验依据。
- 丹参酚对正常骨髓间充质干细胞无抑制,提示治疗窗口可能较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Radix Salviae miltiorrhizae (also called Danshen in traditional Chinese medicine) is a famous herbal medicine, which has been frequently used to treat blood stasis syndrome including osteosarcoma (OS) in traditional Chinese medicine. Main components of Danshen have been assumed to exhibit anti-OS capacity. Nevertheless, tanshinol (TS, main component of Danshen)'s efficacy and mechanism in OS hasn't been clearly described ever since. This drew our attention, since OS is the most frequent primary bone carcinomas in children and adolescents, with a high incidence and fatality rate. Unfortunately, chemotherapy for OS has faced many clinical challenges due to the increasing chemoresistance and recurrence. This study was then designed to deeply explore TS's role in OS therapy. AIM OF THE STUDY: To explore the anti-OS efficacy and mechanism of TS, we conducted in vivo and in vitro experiments by using a zebrafish xenograft model and U2-OS cells. MATERIALS AND METHODS: CCK-8 assay, DAPI and γ-H2A.X immunofluorescence staining, and flow cytometry (apoptosis verification) were employed to determine the anti-proliferative and pro-apoptotic effects of TS. qPCR and Western blot were used to examine TS's molecular actions and mechanism on apoptosis of U2-OS cells. RESULTS: The in vivo data showed that TS significantly inhibited U2-OS tumor growth in larval zebrafish from 2 to 20 ng/mL. In vitro data indicated that TS exerted significant anti-proliferative and pro-apoptotic effects on U2-OS cells in a dose-dependent manner. Moreover, TS has no inhibitory effect on bMSCs, suggesting its safety on normal bone-forming cells. Molecular data illustrated that TS obviously activated the p53 signaling-related proteins (p-p53, Bax, CASP3, CASP9) and its upstream JNK (p-JNK, p-c-JUN) and ATM (p-ATM) signaling molecules through phosphorylation and cleavage, followed by up-regulation of the pro-apoptotic genes, NOXA, PUMA, TP53, BAX, and BIM, and down-regulation of Bcl-2 protein. CONCLUSION: In sum, TS specifically induced apoptosis of U2-OS cells by activating p53 signaling pathways, indicating TS as a promising candidate for OS treatment.
引用
- Yu S, Guo L, Yan B, et al. Tanshinol suppresses osteosarcoma by specifically inducing apoptosis of U2-OS cells through p53-mediated mechanism. J Ethnopharmacol. 2022. PMID: 35331874. doi:10.1016/j.jep.2022.115214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。